Biopharma developing therapies for rare pulmonary and orphan diseases
Insmed is a biopharmaceutical company focused on orphan and pulmonary diseases, running a lab stack of LabWare LIMS, HPLC, ddPCR, qPCR and FlowJo alongside Veeva Vault and Oracle ERP Cloud. Director-heavy hiring weighted toward healthcare, research and commercial roles, plus projects on rare disease sales plans and field force sizing, points to a company building out commercial and safety infrastructure, with Japan pharmacovigilance a clear pressure point.
Notable leadership hires: Pharmacovigilance Director, Regional Director, Commercial Lead, Medical Safety Lead
Insmed Incorporated is a public biopharmaceutical company headquartered in Bridgewater Township, New Jersey, with 1,001–5,000 employees. It develops therapies for serious and rare diseases, with specialties spanning orphan disease states, chronic lung infections and pulmonary medicine. The company operates offices and research sites across the United States, Europe and Japan. Its work covers research, manufacturing, regulatory, medical safety and commercial functions targeting rare disease markets.
Insmed uses lab tools like LabWare LIMS, Chromeleon, HPLC, ddPCR, FlowJo and GraphPad Prism, plus Veeva Vault, Oracle ERP Cloud, Workday, ServiceNow, AWS, GCP, Python and Kubernetes.
Insmed is headquartered in Bridgewater Township, New Jersey, with offices and research locations in the United States, Europe and Japan.
Insmed is hiring in the United States, Japan and Peru, with leadership openings including pharmacovigilance, medical safety and commercial roles.
Other companies in the same industry, closest in size
Insmed Incorporated's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.